Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications.
about
Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia.Role of miRNAs in human disease and inborn errors of metabolism.MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application.A distinct microRNA expression profile is associated with α[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex.Emerging biomarkers of lymphangioleiomyomatosis.
P2860
Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abnormal serum microRNA profil ...... ossible clinical implications.
@en
Abnormal serum microRNA profil ...... ossible clinical implications.
@nl
type
label
Abnormal serum microRNA profil ...... ossible clinical implications.
@en
Abnormal serum microRNA profil ...... ossible clinical implications.
@nl
prefLabel
Abnormal serum microRNA profil ...... ossible clinical implications.
@en
Abnormal serum microRNA profil ...... ossible clinical implications.
@nl
P2093
P2860
P1476
Abnormal serum microRNA profil ...... ossible clinical implications.
@en
P2093
Iwona Dachowska
Joanna Trelinska
Karolina Antosik
Katarzyna Kotulska
Maciej Borowiec
Piotr Gnys
Wojciech Fendler
P2860
P2888
P356
10.1186/S13023-016-0512-1
P577
2016-09-29T00:00:00Z
P6179
1003506303